Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in a neonate - Role of dual therapy: A case report and review of literature

3Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Kaposiform hemangioendothelioma (KHE) represents a rare, borderline vascular tumor with locally aggressive behavior. They are often associated with a potentially life-threatening coagulopathy known as Kasabach-Merritt phenomenon (KMP). Due to heterogeneous nature of the vascular lesion and lack of standardized treatment protocols, these patients pose a diagnostic dilemma and therapeutic challenge with morbidity and potential mortality. We report successful management of an infant with KHE and associated KMP. Difficulties encountered in diagnosis, initiation of therapy, and role of dual therapy with vincristine and steroids are discussed.

Cite

CITATION STYLE

APA

Parashar, G., Shankar, G., Sahadev, R., & Santhanakrishnan, R. (2020, July 1). Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in a neonate - Role of dual therapy: A case report and review of literature. Journal of Indian Association of Pediatric Surgeons. Wolters Kluwer Medknow Publications. https://doi.org/10.4103/jiaps.JIAPS_3_19

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free